Jasper Therapeutics, Inc. (JSPR) NASDAQ
1.22
-0.05(-3.94%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.22
-0.05(-3.94%)
Currency In USD
| Market Cap | 311.81M |
| Enterprise Value | 241.98M |
| P/E Ratio | -0.22 |
| PEG Ratio | -0.12 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.75 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.32 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.58 |
| Return On Equity | -2.62 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -74.87M |
| Net Income | -71.27M |
| Diluted EPS | -4.89 |
| Total Cash | 50.9M |
| Total Cash/Share | 3.07 |
| Total Debt | 1.7M |
| Total Debt/Equity | 0.15 |
| Current Ratio | 2.59 |
| Book Value Per Share | 0.7 |
| 52-Week Change | -77.32 |
| 52-Week High | 7.19 |
| 52-Week Low | 1.11 |
| Moving Average 50 Days | 1.47 |
| Moving Average 200 Days | 2.63 |
| Average Volume | 675,525 |
| Shares Outstanding | 16.25M |
| % Held by Institutions | 115.93 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | January 04, 2024 |